Trimethoprim occurs as bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract contagions (cystitis). It belongs to the class of chemotherapeutic agents known as dihydrofolate reductase inhibitors. Trimethoprim was at one time marketed by GlaxoWellcome under trade names including Proloprim®, Monotrim® & Triprim®; however these brand name keep close at hand been licensed to various generic pharmaceutical manufacturers.

Mechanism of action
Trimethoprim acts by interfering sustaining a action of bacterial dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Folic acid is an essential precursor in the de novo synthesis of the DNA nucleosides thymidine and uridine. Bacterium come unable to require higher folic acid from either the epa (i personally.e. a nausea hikers) so come dependant on their have de novo synthesis - inhibition of a enzyme starves the bacterium of 2 bases necessary for DNA replication and transcription.

Co-trimoxazole
Trimethoprim is usually utilized inside combination by having sulfamethoxazole, a sulfonamide antibiotic, which inhibits the an earliest step in the pteroylglutamic acid synthesis pathway (look at diagram above). This combination, called co-trimoxazole, results around the synergetic antibacterial burden by inhibiting consecutive steps within folacin synthesis. Its apply has been declining due to reports of gantanol bone marrow toxicity.

Clinical indications
Trimethoprim, utilized when monotherapy, is indicated for the prophylaxis & professional assistance of urinary tract infections (cystitis). Co-trimoxazole, owing to its greater efficacy, is indicated for the wider range of contagions. For instance, these are utilized when prophylaxis inside patients at chance for Pneumocystis carinii pneumonia (e.g. AIDS patients and people by using occasionally hematological malignancies), as therapy around Whipple's disease and certain other infections.